Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Gains from Investment Securities (2020 - 2023)

Caribou Biosciences has reported Gains from Investment Securities over the past 4 years, most recently at $170000.0 for Q2 2023.

  • Quarterly Gains from Investment Securities fell 61.55% to $170000.0 in Q2 2023 from the year-ago period, while the trailing twelve-month figure was $170000.0 through Sep 2024, changed 0.0% year-over-year, with the annual reading at $2.1 million for FY2025, N/A changed from the prior year.
  • Gains from Investment Securities was $170000.0 for Q2 2023 at Caribou Biosciences, down from $442167.0 in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $26.2 million in Q1 2022 and troughed at -$119000.0 in Q4 2021.
  • The 4-year median for Gains from Investment Securities is $329730.0 (2020), against an average of $3.2 million.
  • Year-over-year, Gains from Investment Securities tumbled 1290.0% in 2021 and then surged 1581.47% in 2022.
  • A 4-year view of Gains from Investment Securities shows it stood at $10000.0 in 2020, then tumbled by 1290.0% to -$119000.0 in 2021, then soared by 471.57% to $442167.0 in 2022, then crashed by 61.55% to $170000.0 in 2023.
  • Per Business Quant, the three most recent readings for CRBU's Gains from Investment Securities are $170000.0 (Q2 2023), $442167.0 (Q2 2022), and $26.2 million (Q1 2022).